Jorge Vaz Pinto Neto - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Journal of Hematology & Oncology|May 12, 2018

BCL-2 as therapeutic target for hematological malignanciesGuilherme Fleury Perini, Glaciano Nogueira Ribeiro, Jorge Vaz Pinto Neto, et al.

Clinical Lymphoma, Myeloma & Leukemia|January 14, 2025

Expert Opinion on Multiple Myeloma Treatment in Brazil in the Bispecific Antibody EraVania Hungria, Jorge Vaz Pinto Neto, Pedro Manoel Marques Garibaldi, et al.

Psycho-Oncology|August 30, 2016

Development and implementation of a comprehensive psychosocial screening program in a Brazilian cancer centerCristiane Decat Bergerot, Errol J Philip, Tammy A Schuler, et al.

Hematology, Transfusion and Cell Therapy|May 15, 2020

Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committeVania Hungria, Marcia Garnica, Edvan de Queiroz Crusoé, et al.

Hematology, Transfusion and Cell Therapy|September 21, 2019

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantationEdvan De Queiroz Crusoe, Fabiana Higashi, Gracia Martinez, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Journal of Hematology & Oncology|May 12, 2018

BCL-2 as therapeutic target for hematological malignanciesGuilherme Fleury Perini, Glaciano Nogueira Ribeiro, Jorge Vaz Pinto Neto, et al.

Clinical Lymphoma, Myeloma & Leukemia|January 14, 2025

Expert Opinion on Multiple Myeloma Treatment in Brazil in the Bispecific Antibody EraVania Hungria, Jorge Vaz Pinto Neto, Pedro Manoel Marques Garibaldi, et al.

Psycho-Oncology|August 30, 2016

Development and implementation of a comprehensive psychosocial screening program in a Brazilian cancer centerCristiane Decat Bergerot, Errol J Philip, Tammy A Schuler, et al.

Hematology, Transfusion and Cell Therapy|May 15, 2020

Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committeVania Hungria, Marcia Garnica, Edvan de Queiroz Crusoé, et al.

Hematology, Transfusion and Cell Therapy|September 21, 2019

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantationEdvan De Queiroz Crusoe, Fabiana Higashi, Gracia Martinez, et al.

Pageof 1